Skip to main content

Advertisement

Table 2 Univariate analysis of risk factors associated with OS and PFS

From: The predictive value of dynamic monitoring of peripheral blood lymphocyte to monocyte ratio in patients with extranodal NK/T cell lymphoma

Variables OS PFS
HR (95% CI) P value HR (95% CI) P value
Age (> 60 vs. ≤ 60) 1.80 (0.98–3.81) 0.065 1.04 (0.52–2.30) 0.205
Gender (male vs. female) 1.45 (1.07–1.92) 0.052 0.29 (0.13–0.86) 0.905
B symptoms (yes vs. no) 0.68 (0.24–1.63) 0.024 0.35 (0.12–1.98) 0.032
Lugano stage (I–II2 vs. III–IV) 2.28 (1.28–4.14) 0.001 1.52 (0.65–3.58) 0.018
LDH (elevated vs. normal) 1.31 (1.04–1.67) 0.015 0.67 (0.33–1.42) 0.327
Local tumor invasiveness (yes vs. no) 0.46 (0.22–0.96) 0.024 0.32 (0.15–0.66) 0.037
Treatment (chemotherapy or radiotherapy vs. both) 0.67 (0.33–1.42) 0.004 0.35 (0.12–2.30) 0.041
Absolute lymphocyte count (≤ 1.5 × 109/L vs. > 1.5 × 109/L) 1.56 (0.72–3.40) 0.002 1.24 (0.62–2.08) 0.006
Absolute monocyte count (≤ 0.5 × 109/L vs. > 0.5 × 109/L) 0.53 (0.21–1.37) 0.102 0.45 (0.13–2.49) 0.361
LMR (≤ 2.7 vs. > 2.7) 4.21 (1.53–11.56) 0.000 2.78 (1.15–6.76) 0.034